Vibrio cholerae Inaba 48 classical biotype, heat inactivated

DB15485ApprovedInvestigationalVaccines

Vibrio cholerae Inaba 48 classical biotype, heat inactivated: Overview.

First approval
Canada, 2010 · European Union, 2022
Brand names
  • Dukoral

What you can answer from here — as of April 21, 2026

9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10Marketed productsAcross 6 countries and 4 labellers
Sign in

Which companies are running trials of Vibrio cholerae Inaba 48 classical biotype, heat inactivated, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In